View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Vaccination against Covid -19 estimated to cost more than $20bn say leading macroeconomic influencers

By Paul Dennis

4 May

The trillions of dollars in lost GDP due to the Covid-19 pandemic has highlighted the importance of vaccinating the population and realignment of business models in order to reopen the economy.

Investment in vaccination is essential even if the cost is high to ensure that the pandemic does not resurface and cause greater damage in the long run.

George Magnus, an economist, shared an article on the cost of vaccinating billions of people against the Covid-19 disease, which is estimated at $20bn.

He noted that the pandemic is estimated to cost the world more than $2tn in lost GDP.

Magnus added that even if the cost of vaccination is $100bn, it will still be worth the investment to protect both the population and the economy.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena